These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27576954)

  • 1. Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations.
    Pollitt RC; Saraff V; Dalton A; Webb EA; Shaw NJ; Sobey GJ; Mughal MZ; Hobson E; Ali F; Bishop NJ; Arundel P; Högler W; Balasubramanian M
    Am J Med Genet A; 2016 Dec; 170(12):3150-3156. PubMed ID: 27576954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
    Syx D; Guillemyn B; Symoens S; Sousa AB; Medeira A; Whiteford M; Hermanns-Lê T; Coucke PJ; De Paepe A; Malfait F
    J Bone Miner Res; 2015 Aug; 30(8):1445-56. PubMed ID: 25656619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel compound heterozygous BMP1 mutations in a patient with osteogenesis imperfecta: a case report.
    Sangsin A; Kuptanon C; Srichomthong C; Pongpanich M; Suphapeetiporn K; Shotelersuk V
    BMC Med Genet; 2017 Mar; 18(1):25. PubMed ID: 28257626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel homozygous variant in BMP1 associated with a rare osteogenesis imperfecta phenotype.
    Choksi IN; Cox A; Robinson C; Bale A; Carpenter TO
    Osteoporos Int; 2021 Jun; 32(6):1239-1244. PubMed ID: 33624138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in BMP1 result in a patient with autosomal recessive osteogenesis imperfecta.
    Xi L; Lv S; Zhang H; Zhang ZL
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1676. PubMed ID: 33818922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in BMP1 induce a rare type of osteogenesis imperfecta.
    Xu XJ; Lv F; Song YW; Li LJ; Asan ; Wei XX; Zhao XL; Jiang Y; Wang O; Xing XP; Xia WB; Li M
    Clin Chim Acta; 2019 Feb; 489():21-28. PubMed ID: 30408480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta.
    Martínez-Glez V; Valencia M; Caparrós-Martín JA; Aglan M; Temtamy S; Tenorio J; Pulido V; Lindert U; Rohrbach M; Eyre D; Giunta C; Lapunzina P; Ruiz-Perez VL
    Hum Mutat; 2012 Feb; 33(2):343-50. PubMed ID: 22052668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects.
    Valencia M; Caparrós-Martin JA; Sirerol-Piquer MS; García-Verdugo JM; Martínez-Glez V; Lapunzina P; Temtamy S; Aglan M; Lund AM; Nikkels PG; Ruiz-Perez VL; Ostergaard E
    Am J Med Genet A; 2014 May; 164A(5):1143-50. PubMed ID: 24648371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice.
    Muir AM; Ren Y; Butz DH; Davis NA; Blank RD; Birk DE; Lee SJ; Rowe D; Feng JQ; Greenspan DS
    Hum Mol Genet; 2014 Jun; 23(12):3085-101. PubMed ID: 24419319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta.
    Kanno J; Saito-Hakoda A; Kure S; Fujiwara I
    J Bone Miner Metab; 2018 May; 36(3):344-351. PubMed ID: 28528406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Pathogenic Mutations and Responses to Zoledronic Acid in a Cohort of Osteogenesis Imperfecta Children.
    Sun L; Hu J; Liu J; Zhang Q; Wang O; Jiang Y; Xia W; Xing X; Li M
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2571-2579. PubMed ID: 35727737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
    Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal Recessive Osteogenesis Imperfecta Caused by a Novel Homozygous COL1A2 Mutation.
    Costantini A; Tournis S; Kämpe A; Ul Ain N; Taylan F; Doulgeraki A; Mäkitie O
    Calcif Tissue Int; 2018 Sep; 103(3):353-358. PubMed ID: 29572562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants.
    Tüysüz B; Elkanova L; Uludağ Alkaya D; Güleç Ç; Toksoy G; Güneş N; Yazan H; Bayhan AI; Yıldırım T; Yeşil G; Uyguner ZO
    Bone; 2022 Feb; 155():116293. PubMed ID: 34902613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid.
    Xu XJ; Lv F; Liu Y; Wang JY; Ma DD; Asan ; Wang JW; Song LJ; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    J Hum Genet; 2017 Feb; 62(2):205-211. PubMed ID: 27762305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.